Roughly 635,000 new cases of lymphoma were diagnosed worldwide, according to the World Cancer Research Fund International’s most recent report. Survival rates for aggressive lymphomas have improved significantly thanks to advances in treatment, such as chimeric antigen receptor-T cell therapy (CAR-T cell therapy). Dr. Madiha Iqbal, a Mayo Clinic hematologist and oncologist, explains that CAR-T cell therapy is a personalized and innovative treatment giving hope to patients diagnosed with various lymphomas. Watch: The Mayo Clinic Minute https://www.youtube.com/watch?v=3Mhzo1FAmV0 Journalists:…
You may also like
Health & Wellness
Mayo Clinic Q and A: My mom has Alzheimer’s. What does that mean for me?
Editor’s Note: September is World Alzheimer’s Month DEAR MAYO CLINIC: I am part of what I hear called the Sandwich
Health & Wellness
Mayo Clinic Minute: Palliative medicine for cancer patients
Patients undergoing cancer treatments often use palliative medicine to cope with nausea, fatigue and other bothersome symptoms. Palliative medicine is